Ocera Therapeutics Inc (OCRX)

2.10
0.25 10.64
NASDAQ : Health Care
Prev Close 2.35
Open 2.40
Day Low/High 2.10 / 2.45
52 Wk Low/High 1.76 / 4.57
Volume 428.26K
Avg Volume 279.60K
Exchange NASDAQ
Shares Outstanding 23.14M
Market Cap 52.07M
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ocera Therapeutics Announces Late-Breaker Abstract Accepted For Presentation At The AASLD Liver Meeting 2016

Ocera Therapeutics Announces Late-Breaker Abstract Accepted For Presentation At The AASLD Liver Meeting 2016

-- Encouraging Data from NIH-Sponsored Study of OCR-002 in the Treatment of Patients with Acute Liver Failure --

Ocera To Present At The 2016 BIO Investor Forum

Ocera To Present At The 2016 BIO Investor Forum

Company Presentation Scheduled for October 18, 2016 at 8:30 AM PT

Ocera To Present At The Ladenburg Thalmann 2nd Annual Healthcare Conference

Ocera To Present At The Ladenburg Thalmann 2nd Annual Healthcare Conference

Company Presentation Scheduled for September 27, 2016 at 12:00 PM ET

Ocera Announces Management Transition

Ocera Announces Management Transition

Ocera To Present At The JMP Securities Life Sciences Conference

Ocera To Present At The JMP Securities Life Sciences Conference

Company Presentation Scheduled for June 22, 2016 at 11:00 AM ET

Ocera To Present At The Jefferies 2016 Healthcare Conference

Ocera To Present At The Jefferies 2016 Healthcare Conference

-- Company Presentation Scheduled for June 10, 2016 at 11:30 AM ET --

Ocera To Present At The 2016 BIO International Convention

Ocera To Present At The 2016 BIO International Convention

-- Company Presentation Scheduled for June 8, 2016 at 1:00 PM PT --

Ocera Therapeutics Announces Publication Of Promising Preclinical Data In Support Of Its Ammonia Scavenger OCR-002 In The Journal Of Hepatology

Ocera Therapeutics Announces Publication Of Promising Preclinical Data In Support Of Its Ammonia Scavenger OCR-002 In The Journal Of Hepatology

Data show OCR-002 significantly reduced plasma ammonia and portal pressure in portal hypertensive rat models

Ocera To Present At The 15th Annual Needham Healthcare Conference

Ocera To Present At The 15th Annual Needham Healthcare Conference

Company Presentation Scheduled for April 13, 2016 at 3:40 PM ET

Ocera To Present At The Cowen And Company 36th Annual Health Care Conference

Ocera To Present At The Cowen And Company 36th Annual Health Care Conference

Company Presentation Scheduled for March 7, 2016 at 3:20 PM ET

Ocera To Present At The 18th Annual BIO CEO & Investor Conference

Ocera To Present At The 18th Annual BIO CEO & Investor Conference

Company Presentation Scheduled for February 9, 2016 at 10:00 AM ET

Ocera Announces Complete Plasma Data From Pilot Phase 1 Study For Orally-Available OCR-002 In Development For The Prevention Of Chronic Hepatic Encephalopathy

Ocera Announces Complete Plasma Data From Pilot Phase 1 Study For Orally-Available OCR-002 In Development For The Prevention Of Chronic Hepatic Encephalopathy

Study Demonstrated a Robust, Extended-Release Profile for All OCR-002 Prototype Extended-Release Formulations Evaluated

Ocera (OCRX) Stock Rises on Positive Drug Trial Results

Ocera (OCRX) Stock Rises on Positive Drug Trial Results

Ocera (OCRX) stock is gaining in late afternoon trading on Tuesday, after the bio-pharmaceutical company reported positive drug trial results.

Ocera Announces Positive Phase 1 Results For Oral OCR-002 In Development For The Prevention Of Chronic Hepatic Encephalopathy

Ocera Announces Positive Phase 1 Results For Oral OCR-002 In Development For The Prevention Of Chronic Hepatic Encephalopathy

Preliminary Pharmacokinetic Data Demonstrate Promising Extended-Release Profiles

Ocera Therapeutics Highlights OCR-002 Data To Be Presented At The Annual Meeting Of The American Association For The Study Of Liver Diseases (AASLD)

Ocera Therapeutics Highlights OCR-002 Data To Be Presented At The Annual Meeting Of The American Association For The Study Of Liver Diseases (AASLD)

6 Accepted Abstracts Underscore the Potential Breadth of Therapeutic Application for OCR-002

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for under $10 a share look ready to break out and trade higher from current levels.